Cargando…

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation

Cancer cells robustly expel lactate produced through enhanced glycolysis via monocarboxylate transporters (MCTs) and maintain alkaline intracellular pH. To develop a novel therapeutic strategy against multiple myeloma (MM), which still remains incurable, we explored the impact of perturbing a metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanson, Derek James, Nakamura, Shingen, Amachi, Ryota, Hiasa, Masahiro, Oda, Asuka, Tsuji, Daisuke, Itoh, Kohji, Harada, Takeshi, Horikawa, Kazuki, Teramachi, Jumpei, Miki, Hirokazu, Matsumoto, Toshio, Abe, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741786/ https://www.ncbi.nlm.nih.gov/pubmed/26384349

Ejemplares similares

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
por: Amachi, Ryota, et al.
Publicado: (2016)

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
por: Bat-Erdene, Ariunzaya, et al.
Publicado: (2016)

Effective impairment of myeloma cells and their progenitors by hyperthermia
por: Miki, Hirokazu, et al.
Publicado: (2017)

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
por: Teramachi, Jumpei, et al.
Publicado: (2020)

Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling
por: Harada, Takeshi, et al.
Publicado: (2021)

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase
por: Harada, Takeshi, et al.
Publicado: (2022)

Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors
por: Harada, Takeshi, et al.
Publicado: (2013)

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
por: Ashtar, Mohannad, et al.
Publicado: (2020)

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ
por: Iwasa, Masami, et al.
Publicado: (2019)

TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
por: Takeuchi, Kyoko, et al.
Publicado: (2010)

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma
por: Watanabe, Keiichiro, et al.
Publicado: (2021)

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma
por: Tanimoto, Kotaro, et al.
Publicado: (2021)

Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
por: Nakano, Ayako, et al.
Publicado: (2011)

Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL
por: Kagawa, Kumiko, et al.
Publicado: (2012)

Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma
por: Oura, Masahiro, et al.
Publicado: (2023)

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
por: Nakaue, Emiko, et al.
Publicado: (2023)

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression
por: Tenshin, Hirofumi, et al.
Publicado: (2022)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
por: Higa, Yoshiki, et al.
Publicado: (2023)

Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis
por: Sumitani, Ryohei, et al.
Publicado: (2021)

Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma
por: Ozaki, Shuji, et al.
Publicado: (2019)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava
por: Nakamura, Shingen, et al.
Publicado: (2017)

The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease
por: Miki, Hirokazu, et al.
Publicado: (2022)

Monocarboxylate transporters in cancer
por: Payen, Valéry L., et al.
Publicado: (2019)

Monocarboxylate transporters in the brain and in cancer()
por: Pérez-Escuredo, Jhudit, et al.
Publicado: (2016)

Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration
por: Beloueche-Babari, Mounia, et al.
Publicado: (2020)

Roles of monocarboxylate transporter subtypes in promotion and suppression of osteoclast differentiation and survival on bone
por: Imai, Hiroko, et al.
Publicado: (2019)

Exercise-Induced Lactate Release Mediates Mitochondrial Biogenesis in the Hippocampus of Mice via Monocarboxylate Transporters
por: Park, Jonghyuk, et al.
Publicado: (2021)

Prostaglandin E2 Reverses Aberrant Production of an Inflammatory Chemokine by Microglia from Sandhoff Disease Model Mice through the cAMP-PKA Pathway
por: Kawashita, Eri, et al.
Publicado: (2011)

Monocarboxylate Transporters: Role and Regulation in Corneal Diabetes
por: Shrestha, Pawan, et al.
Publicado: (2022)

Monocarboxylate transporter expression at the onset of skeletal muscle regeneration
por: Washington, Tyrone A, et al.
Publicado: (2013)

Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
por: Vancamp, Pieter, et al.
Publicado: (2020)

Cooperative transport mechanism of human monocarboxylate transporter 2
por: Zhang, Bo, et al.
Publicado: (2020)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Distribution of Monocarboxylate Transporters in Brain and Choroid Plexus Epithelium
por: Ueno, Masaki, et al.
Publicado: (2023)

Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells
por: Guo, Chen, et al.
Publicado: (2019)

Magnetically Responsive Smart Nanoparticles for Cancer Treatment with a Combination of Magnetic Hyperthermia and Remote-Control Drug Release
por: Hayashi, Koichiro, et al.
Publicado: (2014)

Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
por: Hayashi, Koichiro, et al.
Publicado: (2013)

Emergence of putative energy parasites within Clostridia revealed by genome analysis of a novel endosymbiotic clade
por: Takahashi, Kazuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dkpol8f3sfl2utofbnun0if52o